title: Androgens protect against apolipoprotein E4-induced cognitive deficits.
abstract: Compared with apolipoprotein (apo) E2 and E3, apoE4 increases the risk of Alzheimer's disease (AD), but it remains unknown how apoE4 affects neuronal function. ApoE4 interacts with female gender, further increasing the risk of AD and decreasing treatment response. Female mice are also more susceptible to apoE4-induced impairments of spatial learning and memory than male mice. To assess the role of sex steroids in this process, we studied mice deficient in mouse apoE (Apoe(-/-)) and expressing human apoE4 or apoE3 in the brain at comparable levels. Even brief periods of androgen treatment improved the memory deficits of female apoE4 mice. Female apoE3 mice had no memory deficits and did not benefit from the treatment. ApoE4 male mice, which performed normally in a water-maze test at baseline, developed prominent deficits in spatial learning and memory after blockade of androgen receptors (ARs), whereas apoE3 male mice did not. Untreated apoE4 mice had significantly lower cytosolic AR levels in the neocortex than wild-type, Apoe(-/-), and apoE3 mice. Improved memory in androgen-treated female apoE4 mice was associated with increased cytosolic AR levels. Our findings suggest that apoE4 contributes to cognitive decline by reducing AR levels in the brain, and that stimulating AR-dependent pathways can reverse apoE4-induced cognitive deficits.
authors.affiliation: Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco, California 94141, USA. raberj@ohsu.edu
authors.forename: Jacob
authors.initials: J
authors.lastname: Raber
authors.forename: Gerold
authors.initials: G
authors.lastname: Bongers
authors.forename: Anthony
authors.initials: A
authors.lastname: LeFevour
authors.forename: Manuel
authors.initials: M
authors.lastname: Buttini
authors.forename: Lennart
authors.initials: L
authors.lastname: Mucke
mesh_terms: D000726:Androgen Antagonists / Q000494:pharmacology; D000728:Androgens / Q000494:pharmacology*; D000818:Animals; D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D001921:Brain / Q000378:metabolism; D003071:Cognition; D003072:Cognition Disorders / Q000517:prevention & control; D013196:Dihydrotestosterone / Q000494:pharmacology; D005260:Female; D005485:Flutamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D018782:Maze Learning; D008568:Memory; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018696:Neuroprotective Agents / Q000494:pharmacology; D011944:Receptors, Androgen / Q000378:metabolism; D021641:Recognition, Psychology; D012737:Sex Factors; D013739:Testosterone / Q000097:blood / Q000494:pharmacology
chemical_list: D000726:Androgen Antagonists; D000728:Androgens; D053318:Apolipoprotein E3; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D018696:Neuroprotective Agents; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; C014290:hydroxyflutamide; D013739:Testosterone; D005485:Flutamide